Back to Search
KENNETH S HU MD
MD
Radiation Oncology Physician
NPI: 1770567406IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
201837(NY)
Education
HARVARD MEDICAL SCHOOL
Class of 1994
Research & Publications (20)
Pharmacokinetics of alpha-naphthyl isothiocyanate in rats.
PMID 16200545·J Pharm Sci·2005
7-preclinical
Impact of anemia in patients with head and neck cancer treated with radiation therapy.
PMID 15610713·Curr Treat Options Oncol·2005
6-review
Point: brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers.
PMID 15737897·Brachytherapy·2005
4-observational
Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport.
PMID 15176077·J Pharm Sci·2004
4-observational
Functional basis of sinus bradycardia in congenital heart block.
PMID 14963005·Circ Res·2004
7-preclinical
The multidisciplinary management of paragangliomas of the head and neck, Part 2.
PMID 12966680·Oncology (Williston Park)·2003
6-review
The cytotoxicity of methyl protodioscin against human cancer cell lines in vitro.
PMID 12901285·Cancer Invest·2003
8-other
Determination of alpha-naphthylisothiocyanate and metabolites alpha-naphthylamine and alpha-naphthylisocyanate in rat plasma and urine by high-performance liquid chromatography.
PMID 12668067·J Chromatogr B Analyt Technol Biomed Life Sci·2003
7-preclinical
The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
PMID 12820229·Phytother Res·2003
7-preclinical
Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer.
PMID 14727239·Semin Oncol·2003
6-review
Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
PMID 11988850·Planta Med·2002
8-other
The cytotoxicity of protoneodioscin (NSC-698789), a furostanol saponin from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
PMID 12403167·Phytomedicine·2002
8-other
High-dose-rate intraoperative irradiation: current status and future directions.
PMID 11813152·Semin Radiat Oncol·2002
6-review
Methyl protogracillin (NSC-698792): the spectrum of cytotoxicity against 60 human cancer cell lines in the National Cancer Institute's anticancer drug screen panel.
PMID 11460001·Anticancer Drugs·2001
8-other
Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels.
PMID 11087218·Am J Physiol Heart Circ Physiol·2000
7-preclinical
Radiotherapy in the management of plasma cell tumors.
PMID 10680152·Oncology (Williston Park)·2000
6-review
Chemically defined medium environment for the development of renal stem cells into tubules.
PMID 17427998·Biotechnol J·2007
7-preclinical
Characterization of the human zinc finger protein 267 promoter: essential role of nuclear factor Y.
PMID 15814297·Biochim Biophys Acta·2005
8-other
Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
PMID 15020301·Am J Physiol Heart Circ Physiol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 160 E 34TH ST, DEPT. OF RADIATION ONCOLOGY
NEW YORK, NY 10016 - Phone
- (212) 731-6033
Quick Facts
- NPI
- 1770567406
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile